Purpose: To promote understanding of cognitive impairment in multiple sclerosis (MS),
recommend optimal screening, monitoring, and treatment strategies, and address barriers to …

Background Cognitive impairment is increasingly being recognized as a common and
disabling symptom of multiple sclerosis (MS) that contributes to poor quality of life in affected …

Cognitive impairment (CI) is a core feature of multiple sclerosis (MS) and affects up to 65%
of patients in every phase of the disease, having a deep impact on all aspects of patients' …

Abstract Purpose of Review Multiple sclerosis (MS) is a demyelinating disease of the central
nervous system that mainly affects young adults and that is one of the leading causes of …

Cognitive deficits as a result of multiple sclerosis (MS) have been documented since the
earliest clinical descriptions of MS 1; yet cognitive decline was not fully acknowledged as a …

Cognitive decline is recognized as a prevalent and debilitating symptom of multiple sclerosis
(MS), especially deficits in episodic memory and processing speed. The field aims to (1) …

Background: Cognitive impairment in MS impacts negatively on many patients at all disease
stages and in all subtypes. Full clinical cognitive assessment is expensive, requiring expert …

Background: With the use of comprehensive neuropsychological assessments, a substantial
proportion of patients with multiple sclerosis have been found to have substantial cognitive …

In Multiple Sclerosis (MS) prevalence studies of community and clinical samples, indicate
that 45–60% of patients are cognitively impaired. These cognitive dysfunctions have been …

Background Cognitive impairment is common in multiple sclerosis (MS) and can have an
impact on all aspects of daily life. It is also an early marker of increased MS disease activity …